@article{quillien:hal-01680957,
TITLE = {Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients},
AUTHOR = {Quillien, V{\'e}ronique and Lavenu, Audrey and Ducray, Fran{\c c}ois and Meyronet, David and Chinot, Olivier and Fina, Fr{\'e}d{\'e}ric and Sanson, Marc and Carpentier, Catherine and Karayan-Tapon, Lucie and Rivet, Pierre and Entz-Werle, Natacha and Legrain, Mich{\`e}le and Zalcman, Emmanu{\`e}le Lechapt and Levallet, Guenaelle and Escande, Fabienne and Ramirez, Carole and Chiforeanu, Dan and Vauleon, Elodie and Figarella-Branger, Dominique},
URL = {https://univ-rennes.hal.science/hal-01680957},
JOURNAL = {Cancer Biomarkers},
PUBLISHER = {IOS Press},
VOLUME = {20},
NUMBER = {4},
PAGES = {435-441},
YEAR = {2017},
MONTH = Dec, DOI = {10.3233/CBM-170191},
KEYWORDS = {MGMT methylation ; pyrosequencing ; Glioblastoma ; CE-IVD kit},
PDF = {https://univ-rennes.hal.science/hal-01680957/file/V2%20Quillien%20et%20al%20-%20Clinical%20validation%20of%20the%20CE-IVD%20-%20Cancer%20Biomarkers.pdf},
HAL_ID = {hal-01680957},
HAL_VERSION = {v1},
}